跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Hameron
Approved
STANDARD
Hameron
Samchundang Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dd222e8d300b113b
Company
Samchundang Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
dd222e8d300b113b
Drug Approval Philippines Name
Hameron
Product Name
Hameron
Registration Number
DRP-4252
Brand Name
Hameron
Generic Name
Sodium Hyaluronate
Dosage Form
Ophthalmic Solution (Drops)
Dosage Strength
1 mg/mL
Manufacturer
Samchundang Pharm. Co., Ltd.
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Bliss Pharma Distribution and Consultancy Corp.
Company Detail Path
/organization/samchundang-pharm-co-ltd
Issuance Date
03 July 2022
Expiry Date
21 May 2027
Pharmacologic Category
Dysfunctional Tear Syndrome (Lubricant)
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dd222e8d300b113b
Type
Standard
Back to Philippines FDA Approvals
Hameron - Philippines FDA Drug Approval Details